Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Addiction and pain.

Sidney H Schnoll1, Michael F Weaver

  • 1Department of Internal Medicine and Psychiatry, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298, USA.

The American Journal on Addictions
|July 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repurposing semaglutide as an adjunctive treatment for cocaine use disorder: protocol for a randomised controlled trial.

BMJ open·2026
Same author

A randomized controlled trial of once-weekly semaglutide for limiting post-smoking cessation weight gain in smokers with overweight/obesity: Study protocol.

Contemporary clinical trials·2025
Same author

E-cigarettes and Youth: The Known, the Unknown, and Implications for Stakeholders.

Journal of addiction medicine·2024
Same author

Contingency management plus acceptance and commitment therapy for initial cocaine abstinence: Results of a sequential multiple assignment randomized trial (SMART).

Drug and alcohol dependence·2024
Same author

Feasibility of Exenatide, a GLP-1R Agonist, for Treating Cocaine Use Disorder: A Case Series Study.

Journal of addiction medicine·2023
Same author

Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and/or overweight: study protocol for a randomised, placebo-controlled clinical trial.

BMJ open·2023

Opioid pain medication can cause dependence and addiction. Physicians must screen patients for addiction using tools like questionnaires and lab tests to ensure appropriate pain management.

Area of Science:

  • Pharmacology
  • Pain Management
  • Addiction Medicine

Background:

  • Opioid analgesics are frequently prescribed for pain but carry risks of adverse effects, including physical dependence, tolerance, and addiction.
  • Undertreatment of pain is common and can lead to drug-seeking behaviors, complicating clinical assessment.
  • Differentiating between undertreated pain, opioid tolerance, and addiction is crucial for effective patient care.

Purpose of the Study:

  • To present the physiological and behavioral consequences of chronic pain and its opioid treatment.
  • To provide guidelines for the appropriate prescribing of opioid pain medication.
  • To highlight the importance of screening for opioid addiction.

Main Methods:

  • Review of physiological and behavioral consequences of chronic pain and opioid therapy.

Related Experiment Videos

  • Discussion of clinical assessment tools for opioid addiction screening, including questionnaires, patient interviews, and laboratory tests.
  • Synthesis of current guidelines for opioid pain medication prescribing.

    • Main Results:

    • Opioid use for analgesia is linked to significant risks such as dependence, tolerance, and addiction.
    • Effective pain management requires careful assessment to distinguish between undertreated pain and addiction.
    • Screening tools are essential for identifying patients with or at risk of opioid addiction.

    Conclusions:

    • Physicians must carefully evaluate pain medication requests, considering undertreatment, tolerance, and addiction.
    • Utilizing screening tools is vital for accurate diagnosis and management of patients on opioid therapy.
    • Adherence to prescribing guidelines can mitigate risks associated with opioid analgesics.